FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1966756850> ?p ?o ?g. }

• W1966756850 endingPage "877" @default.
• W1966756850 startingPage "870" @default.
• W1966756850 abstract "The aim of this study was to compare bone mineral density (BMD) and biochemical markers of bone turnover in patients receiving long-term alendronate therapy who continued alendronate, were switched to raloxifene, or discontinued antiresorptive therapy.Ninety-nine ambulatory women who were diagnosed with postmenopausal osteoporosis and treated with alendronate (10 mg/d) for a mean period of 43 months were randomized to double-blind raloxifene (60 mg/d; n = 33), placebo (n = 33), or continuation of open-label alendronate (n = 33) for 12 months. Patients continued their assigned treatment in a subsequent 12-month, open-label extension phase. All patients received supplemental calcium (500 mg/d) and vitamin D (800 IU/d).BMD (lumbar spine, total femur, femoral neck, distal forearm, and total body) and biochemical markers (serum intact amino-terminal propeptide of type I procollagen, type 1 collagen cross-linked C-telopeptide, and osteocalcin) were measured at baseline and follow-up visits.Discontinuation of alendronate therapy resulted in a decrease in lumbar spine BMD at 12 months (-2.66%; P < 0.05), but did not change total femur BMD (+0.35%; nonsignificant). Raloxifene and alendronate, compared with discontinuation, prevented lumbar spine BMD loss (-0.75% and -0.54% at 12 months, respectively; P < 0.05). Raloxifene and alendronate caused a similar increase in total femur BMD at 12 months (1.45% and 1.56%; both P < 0.05 vs. baseline; nonsignificant vs. discontinuation). Patients, who discontinued alendronate therapy experienced an increase in bone turnover. Bone turnover increases were less pronounced in patients taking raloxifene and were absent in those who continued alendronate. Of the three groups, mean bone turnover in raloxifene patients was the closest to premenopausal mean values.BMD preservation and increase were most pronounced in patients continuing alendronate. Raloxifene treatment, compared with placebo, demonstrated beneficial effects on BMD and bone turnover after discontinuation of long-term alendronate therapy." @default.
• W1966756850 created "2016-06-24" @default.
• W1966756850 creator A5024332390 @default.
• W1966756850 creator A5026505577 @default.
• W1966756850 creator A5039076527 @default.
• W1966756850 creator A5050840013 @default.
• W1966756850 date "2006-03-01" @default.
• W1966756850 modified "2023-10-14" @default.
• W1966756850 title "The Effect of Raloxifene after Discontinuation of Long-Term Alendronate Treatment of Postmenopausal Osteoporosis" @default.
• W1966756850 cites W1916689057 @default.
• W1966756850 cites W1969564030 @default.
• W1966756850 cites W1969945802 @default.
• W1966756850 cites W1985160737 @default.
• W1966756850 cites W1987401403 @default.
• W1966756850 cites W1989783674 @default.
• W1966756850 cites W1990654348 @default.
• W1966756850 cites W2000204187 @default.
• W1966756850 cites W2001013535 @default.
• W1966756850 cites W2006021879 @default.
• W1966756850 cites W2007614714 @default.
• W1966756850 cites W2022094899 @default.
• W1966756850 cites W2023781848 @default.
• W1966756850 cites W2025103357 @default.
• W1966756850 cites W2036257783 @default.
• W1966756850 cites W2051096613 @default.
• W1966756850 cites W2057332307 @default.
• W1966756850 cites W2060164580 @default.
• W1966756850 cites W2062781570 @default.
• W1966756850 cites W2067327441 @default.
• W1966756850 cites W2077308807 @default.
• W1966756850 cites W2090457064 @default.
• W1966756850 cites W2090640733 @default.
• W1966756850 cites W2091806192 @default.
• W1966756850 cites W2104949625 @default.
• W1966756850 cites W2112629831 @default.
• W1966756850 cites W2113550509 @default.
• W1966756850 cites W2127985847 @default.
• W1966756850 cites W2151746268 @default.
• W1966756850 cites W2152063648 @default.
• W1966756850 cites W2153009489 @default.
• W1966756850 cites W2161837912 @default.
• W1966756850 cites W2168776590 @default.
• W1966756850 cites W2170750104 @default.
• W1966756850 cites W2270975625 @default.
• W1966756850 doi "https://doi.org/10.1210/jc.2004-2212" @default.
• W1966756850 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16352692" @default.
• W1966756850 hasPublicationYear "2006" @default.
• W1966756850 type Work @default.
• W1966756850 sameAs 1966756850 @default.
• W1966756850 citedByCount "39" @default.
• W1966756850 countsByYear W19667568502012 @default.
• W1966756850 countsByYear W19667568502013 @default.
• W1966756850 countsByYear W19667568502015 @default.
• W1966756850 countsByYear W19667568502016 @default.
• W1966756850 countsByYear W19667568502017 @default.
• W1966756850 countsByYear W19667568502020 @default.
• W1966756850 countsByYear W19667568502021 @default.
• W1966756850 countsByYear W19667568502022 @default.
• W1966756850 countsByYear W19667568502023 @default.
• W1966756850 crossrefType "journal-article" @default.
• W1966756850 hasAuthorship W1966756850A5024332390 @default.
• W1966756850 hasAuthorship W1966756850A5026505577 @default.
• W1966756850 hasAuthorship W1966756850A5039076527 @default.
• W1966756850 hasAuthorship W1966756850A5050840013 @default.
• W1966756850 hasBestOaLocation W19667568501 @default.
• W1966756850 hasConcept C121608353 @default.
• W1966756850 hasConcept C125870589 @default.
• W1966756850 hasConcept C126322002 @default.
• W1966756850 hasConcept C126894567 @default.
• W1966756850 hasConcept C131075544 @default.
• W1966756850 hasConcept C134018914 @default.
• W1966756850 hasConcept C141071460 @default.
• W1966756850 hasConcept C142724271 @default.
• W1966756850 hasConcept C160160445 @default.
• W1966756850 hasConcept C170033053 @default.
• W1966756850 hasConcept C181199279 @default.
• W1966756850 hasConcept C185592680 @default.
• W1966756850 hasConcept C204787440 @default.
• W1966756850 hasConcept C27081682 @default.
• W1966756850 hasConcept C2775854910 @default.
• W1966756850 hasConcept C2776541429 @default.
• W1966756850 hasConcept C2776886416 @default.
• W1966756850 hasConcept C2778715236 @default.
• W1966756850 hasConcept C2779809032 @default.
• W1966756850 hasConcept C2779889926 @default.
• W1966756850 hasConcept C530470458 @default.
• W1966756850 hasConcept C55493867 @default.
• W1966756850 hasConcept C71924100 @default.
• W1966756850 hasConcept C84606932 @default.
• W1966756850 hasConceptScore W1966756850C121608353 @default.
• W1966756850 hasConceptScore W1966756850C125870589 @default.
• W1966756850 hasConceptScore W1966756850C126322002 @default.
• W1966756850 hasConceptScore W1966756850C126894567 @default.
• W1966756850 hasConceptScore W1966756850C131075544 @default.
• W1966756850 hasConceptScore W1966756850C134018914 @default.
• W1966756850 hasConceptScore W1966756850C141071460 @default.
• W1966756850 hasConceptScore W1966756850C142724271 @default.
• W1966756850 hasConceptScore W1966756850C160160445 @default.

• next